BIO Europe - 30th Annual International Partnering Conference
Name:
BIO Europe - 30th Annual International Partnering Conference
Date:
November 4, 2024 - November 6, 2024
Website:
Learn more and register.
Event Description:
Join the 30th anniversary edition of BIO-Europe, the biopharma partnering event that has grown with the industry, innovated alongside it, and remains the gathering place for meaningful and memorable conversations and connections. In 2023, BIO-Europe reached new levels of attendance, engagement, and collaboration. 2024 promises to deliver quality opportunities for connection and partnering.
The 30th annual BIO-Europe will convene over 5,500 life science professionals representing more than 2,800 companies from over 60 countries. Attendees will take part in 29,000 one-to-one meetings over the course of the event.
Over the last 30 years, BIO-Europe, has become Europe’s flagship partnering event. Its international reach makes it a one-of-a-kind offering, with attendees from all parts of the biotechnology value chain gathering to efficiently identify, engage and form strategic relationships that drive their businesses successfully forward.
BIO-Europe delivers for all the players of the biopharma community, providing startup and innovator programs, insights on industry trends from KOLs, the gold standard of partnering systems as well as ample serendipitous networking opportunities. The combination of activities and the combination of participants delivers an unprecedented ROI.
EBD Group continues to be committed to providing a forum for the entire global biopharma community to come together. As part of this commitment, two days of digital partnering are offered in the week following the in-person event.
EBD’s partneringONE® platform has become more powerful than ever before. The entire event can be accessed via a single login, and the industry-specific search tool will support your partner search. Scheduled meetings will take place face-to-face during the live conference and digitally during the digital partnering days with links to a video conferencing solution. Additionally, on-demand content will be made available leading up to the event, during the event, and during the digital days.
BIO-Europe is produced by EBD Group, the leading partnering firm for the global biotechnology industry, with the support of the Biotechnology Innovation Organization.
The 30th annual BIO-Europe will convene over 5,500 life science professionals representing more than 2,800 companies from over 60 countries. Attendees will take part in 29,000 one-to-one meetings over the course of the event.
Over the last 30 years, BIO-Europe, has become Europe’s flagship partnering event. Its international reach makes it a one-of-a-kind offering, with attendees from all parts of the biotechnology value chain gathering to efficiently identify, engage and form strategic relationships that drive their businesses successfully forward.
BIO-Europe delivers for all the players of the biopharma community, providing startup and innovator programs, insights on industry trends from KOLs, the gold standard of partnering systems as well as ample serendipitous networking opportunities. The combination of activities and the combination of participants delivers an unprecedented ROI.
EBD Group continues to be committed to providing a forum for the entire global biopharma community to come together. As part of this commitment, two days of digital partnering are offered in the week following the in-person event.
EBD’s partneringONE® platform has become more powerful than ever before. The entire event can be accessed via a single login, and the industry-specific search tool will support your partner search. Scheduled meetings will take place face-to-face during the live conference and digitally during the digital partnering days with links to a video conferencing solution. Additionally, on-demand content will be made available leading up to the event, during the event, and during the digital days.
BIO-Europe is produced by EBD Group, the leading partnering firm for the global biotechnology industry, with the support of the Biotechnology Innovation Organization.
